Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function

@article{Iversen2001NonsteroidalAA,
  title={Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function},
  author={P. Iversen and I. Melez{\'i}nek and A. Schmidt},
  journal={BJU International},
  year={2001},
  volume={87}
}
The quality of life of men with prostate cancer is receiving increasing attention and, acknowledging that endocrine therapy conceptually remains a palliative treatment, many patients view the preservation of quality of life to be an equally important goal of therapy as the prolongation of survival [1]. The issue of quality of life is further emphasized by moves to initiate endocrine therapy earlier in the course of the disease and in younger men. Sexuality is an important aspect of quality of… Expand
An evaluation of bicalutamide in the treatment of prostate cancer
Bicalutamide (Casodex®) in the treatment of prostate cancer
  • Y. Fradet
  • Medicine
  • Expert review of anticancer therapy
  • 2004
Emerging role of adjuvant hormonal therapy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 93 REFERENCES
Quality of Life Issues Relating to Endocrine Treatment Options
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
...
1
2
3
4
5
...